Back to results
US 2025/0152555 A1Published application
Pharmaceutical Composition for Preventing or Treating Triple-Negative Breast Cancer
AssigneeDaewoong Pharmaceutical Co., Ltd.
InventorsAhreum Kwon, Kwon Jo Lim, Ji Duck Kim, Joon Seok Park
Life of this patent
Estimating the term…
Abstract
The present invention provides a pharmaceutical composition comprising a compound represented by Chemical Formula 1 described in the present specification, or a pharmaceutically acceptable salt thereof, and a chemotherapeutic agent. The pharmaceutical composition can be usefully used for preventing or treating triple-negative breast cancer.
Claims6
A method for preventing or treating triple-negative breast cancer in a subject in need thereof, comprising administering to the subject:
- a compound represented by the following Chemical Formula 1, or a pharmaceutically acceptable salt thereof, and
- a chemotherapeutic agent:
Dependencies are inferred from the claim text.